The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification, incidence and clinical outcomes of patients (pts) with hypermutated prostate cancer (PC).
 
Simon Yuen Fai Fu
Travel, Accommodations, Expenses - Roche; Roche; Roche/Genentech
 
Elie Ritch
No Relationships to Disclose
 
Cameron Herberts
No Relationships to Disclose
 
Steven Yip
Consulting or Advisory Role - Bayer
 
Daniel Khalaf
Consulting or Advisory Role - Bayer
 
Evan W Warner
No Relationships to Disclose
 
Sinja Taavitsainen
No Relationships to Disclose
 
Matti Annala
No Relationships to Disclose
 
Gillian Vandekerkhove
No Relationships to Disclose
 
Igal Kushnir
Stock and Other Ownership Interests - Teva
 
Cristiano Ferrario
Honoraria - AstraZeneca; Bayer; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Genomic Health; Merck
Speakers' Bureau - Novartis
Research Funding - Amgen; Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Cascadian Therapeutics (Inst); Celldex (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Alexander William Wyatt
Consulting or Advisory Role - Genzyme
Speakers' Bureau - Janssen
Research Funding - Janssen
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)